ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "inflammatory arthritis"

  • Abstract Number: 3251 • 2016 ACR/ARHP Annual Meeting

    Sleep and Physical Activity: A Nationwide Survey Among People with Rheumatic Disease in Ireland

    Sean McKenna1, Alan Donnelly2, Sandy Fraser3 and Norelee Kennedy1, 1Department of Clinical Therapies, University of Limerick, Ireland, Limerick, Ireland, 2Department of Physical Education and Sports Sciences, University of Limerick, Ireland, Limerick, Ireland, 3Department of Rheumatology, University Hospitals Limerick, Ireland, Limerick, Ireland

    Background/Purpose:   Sleep is an important aspect in maintaining the body’s circadian rhythm and plays an important role in maintaining health. Disrupted or lower levels…
  • Abstract Number: 19 • 2016 ACR/ARHP Annual Meeting

    Tumour Necrosis Factor Inhibition Is Associated with Weight Gain in Patients with Inflammatory Arthritis

    Peter Wong1, Alison Bowling2, Cheryl Tulk3, Di Freeman3 and Hanish Bagga3, 1Mid-North Coast Arthritis Clinic and University of New South Wales Rural Clinical School, Coffs Harbour, Australia, 2School of Health and Human Sciences, Southern Cross University, Coffs Harbour, Australia, 3Mid-North Coast Arthritis Clinic, Coffs Harbour, Australia

    Background/Purpose: Targeted blockade of tumour necrosis factor (TNF) has been a major therapeutic advance in the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA) and…
  • Abstract Number: 479 • 2015 ACR/ARHP Annual Meeting

    How to Recruit Anti-CCP Positive Patients from Primary Care

    Jackie L. Nam1, Laura Hunt1, Elizabeth M.A. Hensor1 and Paul Emery1,2, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2Division of Rheumatic and Musculoskeletal Disease, University of Leeds, Leeds Institute of Molecular Medicine and LMBRU, Leeds, United Kingdom

    Background/Purpose: Around 1% of the population test positive for anti-cyclic citrullinated peptide (anti-CCP) antibodies. This biomarker predicts progression to rheumatoid arthritis (RA) but over a…
  • Abstract Number: 933 • 2015 ACR/ARHP Annual Meeting

    DEK-Targeting DNA Aptamers As Novel Therapeutics for Inflammatory Arthritis

    Nirit Mor-Vaknin1, Anjan K. Saha2, Maureen Legendre1, Carmelo Carmona-Rivera3, M. Asif Amin4, Bradley J. Rabquer5, Marta J. Gonzalez-Hernandez6, Julie M. Jorns7, Srilakshmi Yalavarthi8, Smriti Mohan9, Dave Pai10, Kristine Angevine11, Barbara Adams12, Jason S. Knight8, Alisa E. Koch13,14,15, David Fox14, Dave Engelke16, Mariana J. Kaplan17 and David Markovitz4, 1Infectious Diseases, University of Michigan, Ann Arbor, MI, 2Medical School, University of Michigan, Ann Arbor, MI, 3Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4Internal Medicine, University of Michigan, Ann Arbor, MI, 5Albion College, Ann Arbor, MI, 6Graduate Program in Immunology, University of Michigan, Ann Arbor, MI, 7Pathology, University of Michigan, Ann Arbor, MI, 8Division of Rheumatology, University of Michigan, Ann Arbor, MI, 9Pediatric Rheumatology, University of Michigan, Ann Arbor, MI, 10Scripps Research Institute, San Diego, CT, 11Appistry, Inc, St. Louis, MO, 12Pediatric Rheum PTD, Univ of Michigan Hlth System, Ann Arbor, MI, 13VA Medical Service, Ann Arbor, MI, 14Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 15Internal Medicine, Veteran's Affairs and University of Michigan, Ann Arbor, MI, 16Biochemistry, University Michigan, Ann Arbor, MI, 17Systemic Autoimmunity Branch, NIAMS, National Institutes of Health, Bethesda, MD

    Background/Purpose: Aptamers are short single stranded DNA or RNA oligonucleotides that are specifically selected to bind and neutralize a wide range of biomedically relevant proteins.…
  • Abstract Number: 1176 • 2015 ACR/ARHP Annual Meeting

    Interleukin-37 Prevents New-Onset Joint Inflammation but Does Not Inhibit Existing Experimental Arthritis

    Marije I. Koenders1, Debbie M. Roeleveld1, Charles Dinarello2, Peter M. van der Kraan1 and Leo Joosten3, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 2Department of Medicine, Division of Infectious Diseases, University of Colorado, Denver, CO, 3Internal Medicine, Radboud university medical center, Nijmegen, Netherlands

    Background/Purpose: Interleukin-37 (IL-37) is a recently identified cytokine with potent anti-inflammatory and immunosuppressive functions. This cytokine has been shown to be expressed in synovial tissue…
  • Abstract Number: 1192 • 2015 ACR/ARHP Annual Meeting

    The F-Word: Why Is Talking about Fatigue so Hard?

    Ruth Hart1, Katie Hackett2, Julia Newton3, Wan-Fai Ng3,4 and Ben Thompson4,5, 1Institute of Health and Society, Newcastle University, Newcastle upon Tyne, United Kingdom, 2Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 3Newcastle University, Newcastle upon Tyne, United Kingdom, 4Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom, 5Newcastle University, Newcastle-upon-Tyne, United Kingdom

    Background/Purpose: Fatigue is a common symptom for people with inflammatory arthritis and associated auto-immune conditions. Its impact is wide-ranging and significantly reduces health-related quality of…
  • Abstract Number: 1354 • 2015 ACR/ARHP Annual Meeting

    Whipple’s Disease: The Diagnostic Utility of Synovial Fluid Tropheryma Whipplei Polymerase Chain Reaction

    Zoran Kvrgic1, Kelly Cawcutt2, Robin Patel3, Abinash Virk2, Clement J. Michet Jr.4, Eric L. Matteson5 and Tim Bongartz1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Infectious Diseases, Mayo Clinic, Rochester, MN, 3Medicine, Mayo Clinic, Rochester, MN, 4Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose: Inflammatory arthritis is a common, non-specific symptom of Whipple’s disease. Recovery of the organism by conventional culture is often unsuccessful. Synovial fluid polymerase chain…
  • Abstract Number: 1480 • 2015 ACR/ARHP Annual Meeting

    Adiposity in Children with Juvenile Psoriatic Arthritis (JPsA)

    Aaida Samad1, Matthew L. Stoll2, Idit Lavi3, Kriti Gupta1, Joyce Hsu4, Vibeke Strand5,6, Elizabeth D. Mellins7, Devy Zisman8 and for the CARRA Registry Investigators, 1Dept of Pediatrics CSSR, Stanford University Med Ctr, Stanford, CA, 2University of Alabama at Birmingham, Birmingham, AL, 3Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel, 4Pediatric Rheumatology, Stanford University, Palo Alto, CA, 5Stanford University, Palo Alto, CA, 6Biopharmaceutical Consultant, Portola Valley, CA, 7Dept of Pediatrics CCSR, Stanford University Med Ctr, Stanford, CA, 8Rheumatology Unit, Carmel Medical CenterThe Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel, Haifa, Israel

    Background/Purpose: To assess the adiposity/BMI of children diagnosed with JPsA in a North American registry, examining differences between overweight and non-overweight patients with regard to…
  • Abstract Number: 2019 • 2015 ACR/ARHP Annual Meeting

    Serum Biomarkers of Inflammatory Arthritis in First Degree Relatives of Patients with Rheumatoid Arthritis and Their Association with Lifestyle Risk Factors

    Jamie C Sergeant and RA-MAP Consortium, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom, Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom

    Background/Purpose: Rheumatoid factor (RF), anti-cyclic citrullinated peptide antibodies (anti-CCP) and C-reactive protein (CRP) are known serum biomarkers of inflammatory arthritis (IA) and have potential predictive…
  • Abstract Number: 2263 • 2015 ACR/ARHP Annual Meeting

    Construct and Convergent Validity of Four Global Measures of at-Work Productivity Loss in Patients with Rheumatic Diseases

    Sarah Leggett1, Diane Lacaille2, Carina Mihai3, Mihai Bojinca4, Brendan van As5, Suzanne M. Verstappen6 and EULAR-PRO worker productivity group, 1Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre,The University of Manchester, Manchester, United Kingdom, 2Arthritis Research Centre, University of British Columbia, Vancouver, BC, Canada, 3Internal Medicine and Rheumatology, Ion Cantacuzino Hospital, Bucharest, Romania, 4Carol Davila University of Medicine and Pharmacy, Internal Medicine and Rheumatology, Cantacuzino Hospital, Bucharest, Romania, 5Arthritis Research Canada, Richmond, BC, Canada, 6Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: Several global measures are available to assess at-work productivity loss in rheumatic diseases. Paucity in research exploring the construct validity of such measures contributes…
  • Abstract Number: 2318 • 2015 ACR/ARHP Annual Meeting

    Inflammatory Arthritis Patient Perspectives on Strategies to Support Medication Adherence: A Qualitative Study Using a Novel Group Exercise

    Sharan K. Rai1, Pavandeep Mehat2, Anne Townsend3, Carlo Marra4, Harpreet Chhina5, Rhonda Shuckett6 and Mary A. De Vera2, 1Experimental Medicine, University of British Columbia, Vancouver, BC, Canada, 2Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 3Medical School, University of Exeter, Exeter, United Kingdom, 4School of Pharmacy, Memorial University, St. John's, NF, Canada, 5Orthopedic Surgery, BC Children's Hospital, Vancouver, BC, Canada, 6Rheumatology, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Disappointing and inconsistent findings of adherence intervention research in inflammatory arthritis (IA) highlight the need for further work in designing interventions that promote and…
  • Abstract Number: 2576 • 2015 ACR/ARHP Annual Meeting

    Treatment of Inflammatory Arthritis with a Hybrid Compound, LLP2A-Ale, Can Prevent Joint Destruction

    Nancy E. Lane1, Wei Yao2 and Maripat Corr3, 1Center for Musculoskeletal Health, Univ of California at Davis, Sacramento, CA, 2University California, Davis Medical Center, Internal Medicine, Sacramento, CA, 3Medicine, University of California, San Diego, La Jolla, CA

    Background/Purpose: Nearly 2% of the US population suffers from inflammatory arthritis, and while there are effective treatments that reduce the joint destruction, over 20% of…
  • Abstract Number: 3188 • 2015 ACR/ARHP Annual Meeting

    Inhibition of Lymphatic Muscle Contraction By Lymphatic Endothelial iNOS Impairs Lymph Drainage from Arthritic Joints in TNF-Tg Mice and Is Prevented By Herbal Drugs

    Qianqian Liang1, Yan Chen1, Jinlong Li1, Wensheng Wang2, Li Zhang1, Hao Xu1, Ronald Wood2, Brendan Boyce2, Edward Schwarz3, Yongjun Wang1 and Lianping Xing4, 1Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China, 2University of Rochester, Rochester, NY, 3Orthopedeatrics, University of Rochester, Rochester, NY, 4University of Rochester Medical Center, Rochester, NY

    Background/Purpose: We reported previously that inflammation in TNF-Tg mice, a model of rheumatoid arthritis (RA), inhibits lymphatic vessel maturation, resulting in decreased lymphatic smooth muscle…
  • Abstract Number: 3190 • 2015 ACR/ARHP Annual Meeting

    Netrin-1 and Its Receptor Unc5b Are Novel Targets for the Treatment of Inflammatory Arthritis

    Aranzazu Mediero1, Tuere Wilder2 and Bruce Cronstein3, 1Medicine, Divison of Translational Medicine, NYU School of Medicine, New York City, NY, 2Dept of Med, Div of Rheum, NYU School of Medicine, New York, NY, 3Medicine, Division of Rheumatology, NYU School of Medicine, NEW YORK, NY

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation and destruction of the joints and some extra-articular tissues. Netrin-1 is a laminin-like…
  • Abstract Number: 34 • 2015 ACR/ARHP Annual Meeting

    The Impact of Cardiovascular and Lung Disorder Morbidities on Physical Activity in People with Inflammatory Arthritis Compared to the General Population in the UK

    Michael Cook1, Eftychia Bellou2, Jamie C Sergeant3, John Bowes2, Anne Barton4, Terence W. O'Neill1 and Suzanne M.M. Verstappen1, 1Arthritis Research UK Centre for Epidemiology, The University of Manchester, Centre for Musculoskeletal Research, Manchester, United Kingdom, 2Arthritis Research UK Centre for Genetics and Genomics, The University of Manchester, Centre for Musculoskeletal Research, Manchester, United Kingdom, 3NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom, 4NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academic Health Science Centre, Manchester, United Kingdom

    Background/Purpose: Cardiovascular and lung disorder morbidities are more common in people with inflammatory arthritis (IA) than in the general population.  However, little is known about…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology